India · Delayed Price · Currency is INR Aurobindo Pharma Statistics
Total Valuation
NSE:AUROPHARMA has a market cap or net worth of INR 850.00 billion. The enterprise value is 824.47 billion.
| Market Cap | 850.00B |
| Enterprise Value | 824.47B |
Important Dates
The last earnings date was Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AUROPHARMA has 580.80 million shares outstanding. The number of shares has decreased by -0.35% in one year.
| Current Share Class | 580.80M |
| Shares Outstanding | 580.80M |
| Shares Change (YoY) | -0.35% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 15.22% |
| Owned by Institutions (%) | 39.72% |
| Float | 278.95M |
Valuation Ratios
The trailing PE ratio is 24.25 and the forward PE ratio is 19.14. NSE:AUROPHARMA's PEG ratio is 1.22.
| PE Ratio | 24.25 |
| Forward PE | 19.14 |
| PS Ratio | 2.53 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | 29.92 |
| P/OCF Ratio | 15.38 |
| PEG Ratio | 1.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.02, with an EV/FCF ratio of 29.02.
| EV / Earnings | 23.52 |
| EV / Sales | 2.45 |
| EV / EBITDA | 12.02 |
| EV / EBIT | 16.23 |
| EV / FCF | 29.02 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.81 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.18 |
| Debt / FCF | 2.84 |
| Interest Coverage | 13.22 |
Financial Efficiency
Return on equity (ROE) is 9.93% and return on invested capital (ROIC) is 10.05%.
| Return on Equity (ROE) | 9.93% |
| Return on Assets (ROA) | 5.86% |
| Return on Invested Capital (ROIC) | 10.05% |
| Return on Capital Employed (ROCE) | 12.55% |
| Weighted Average Cost of Capital (WACC) | 4.31% |
| Revenue Per Employee | 12.15M |
| Profits Per Employee | 1.26M |
| Employee Count | 27,707 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.19 |
Taxes
In the past 12 months, NSE:AUROPHARMA has paid 16.09 billion in taxes.
| Income Tax | 16.09B |
| Effective Tax Rate | 31.47% |
Stock Price Statistics
The stock price has increased by +21.92% in the last 52 weeks. The beta is 0.03, so NSE:AUROPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +21.92% |
| 50-Day Moving Average | 1,382.20 |
| 200-Day Moving Average | 1,203.81 |
| Relative Strength Index (RSI) | 52.91 |
| Average Volume (20 Days) | 1,300,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AUROPHARMA had revenue of INR 336.53 billion and earned 35.05 billion in profits. Earnings per share was 60.34.
| Revenue | 336.53B |
| Gross Profit | 201.65B |
| Operating Income | 50.78B |
| Pretax Income | 51.12B |
| Net Income | 35.05B |
| EBITDA | 68.56B |
| EBIT | 50.78B |
| Earnings Per Share (EPS) | 60.34 |
Balance Sheet
The company has 106.18 billion in cash and 80.73 billion in debt, with a net cash position of 25.45 billion or 43.81 per share.
| Cash & Cash Equivalents | 106.18B |
| Total Debt | 80.73B |
| Net Cash | 25.45B |
| Net Cash Per Share | 43.81 |
| Equity (Book Value) | 378.83B |
| Book Value Per Share | 652.31 |
| Working Capital | 146.70B |
Cash Flow
In the last 12 months, operating cash flow was 55.26 billion and capital expenditures -26.86 billion, giving a free cash flow of 28.41 billion.
| Operating Cash Flow | 55.26B |
| Capital Expenditures | -26.86B |
| Depreciation & Amortization | 17.78B |
| Net Borrowing | -6.93B |
| Free Cash Flow | 28.41B |
| FCF Per Share | 48.91 |
Margins
Gross margin is 59.92%, with operating and profit margins of 15.09% and 10.41%.
| Gross Margin | 59.92% |
| Operating Margin | 15.09% |
| Pretax Margin | 15.19% |
| Profit Margin | 10.41% |
| EBITDA Margin | 20.37% |
| EBIT Margin | 15.09% |
| FCF Margin | 8.44% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 6.63% |
| Buyback Yield | 0.35% |
| Shareholder Yield | 0.90% |
| Earnings Yield | 4.12% |
| FCF Yield | 3.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |